Kathleen Harnden, MD MBA
From the Inova website
Dr. Kathleen Harnden is a specialty care physician board certified in medical oncology and internal medicine at Inova Health System. She has a special interest in the management of breast cancer, particularly in premenopausal women.
Dr. Harnden joined Inova Schar Cancer Institute after the completion of her hematology/oncology fellowship at Duke University Medical Center in Durham, NC. She is an MBA graduate from the University of Virginia Darden School of Business.
Dr. Harnden has numerous publications in national journals and has presented at national meetings on topics in breast cancer. Her research has focused on early phase clinical trials in breast cancer, breast cancer genomics and individualized treatment for patients based on advanced testing results. She is and has been a principal investigator on several phase I clinical trials in metastatic breast cancer and is interested in developing novel therapies for breast cancer.
Financial relationships
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:PfizerTopic:advisory boardDate added:10/25/2023Date updated:10/25/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:SeaGenTopic:physician speakerDate added:10/25/2023Date updated:10/25/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:MerckTopic:physician speakerDate added:10/25/2023Date updated:10/25/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Daiichi SankyoTopic:physician speakerDate added:10/25/2023Date updated:10/25/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:AstrazenecaTopic:physician speakerDate added:10/25/2023Date updated:10/25/2023